The rates of coronary reperfusion in the accelerated SK plus enoxaparin (77.6%) and accelerated SK plus UFH (73.5%) groups were similar but both were significantly higher than that observed in the standard SK plus UFH group (62.2%) ( P = 0.002 and 0.013, respectively). The present study showed lower in-hospital mortality among patients who received accelerated SK regimen (2%) compared to those who received traditional regimen (4%) although it did not reach statistical significance.
← all excerpts
Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen.
1
—
—